Arun R. Pandiri

Arun R. Pandiri

Auto-generated profile, based on publicly available information

Arun R. Pandiri

Experimental Pathology Laboratories, Inc., Research Triangle Park, North Carolina, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2013 in Toxicologic Pathology
Verified
Journal Article
Open access
PDF file
APArun R. Pandiri
Arun R. Pandiri
Exocrine pancreas is a source of several enzymes that are essential for the digestive process. The exocrine pancreatic secretion is tightly regulated by the neuroendocrine system. The endocrine pancreas is tightly integrated anatomically and physiologically with the exocrine pancreas and modulates its function. Compound-induced pancreatitis is not a common event in toxicology or drug development, but it becomes a significant liability when encountered. Understanding the species-specific differences in physiology is essential to understand the underlying pathobiology of pancreatic disease in animal models and its relevance to human disease. This review will mainly focus on understanding the morphology and physiology of the pancreas, unique islet–exocrine interactions, and pancreatitis.

23 October 2016 in Toxicologic Pathology
Verified
Journal Article
Open access
PDF file
APArun R. Pandiri
Arun R. Pandiri
RKRoy L. Kerlin
Roy L. Kerlin
PMPeter C. Mann
Peter C. Mann
NENancy E. Everds
Nancy E. Everds
ASAlok K. Sharma
Alok K. Sharma
TSThomas J. Steinbach
Thomas J. Steinbach
One of the principal challenges facing a toxicologic pathologist is to determine and differentiate a true adverse effect from a nonadverse or an adaptive response. Recent publications from the Society of Toxicologic Pathology (STP) and the European STP provide guidance for determining and communicating adversity in nonclinical toxicology studies. In order to provide a forum to inform and engage in a discussion on this important topic, a continuing education (CE) course was held during the 2016 STP Annual meeting in San Diego, CA. The lectures at this course provided guidance on determining and communicating adversity using case studies involving both clinical pathology and anatomic pathology. In addition, one talk also focused on data quality, study design, and interpretation of artifacts that could hinder the determination of adversity. The CE course ended with a talk on understanding adversity in preclinical studies and engaging the regulatory agencies in the decision-making process. This manuscript is designed to provide brief summaries of all the talks in this well-received CE course.

11 April 2022 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
JCJ. Christopher Corton
J. Christopher Corton
CMConstance Mitchell
Constance Mitchell
SAScott Auerbach
Scott Auerbach
PBPierre Bushel
Pierre Bushel
HEHeidrun Ellinger-Ziegelbauer
Heidrun Ellinger-Ziegelbauer
FSFrank D Sistare
Frank D Sistare
There is growing recognition across broad sectors of the scientific community that use of genomic biomarkers has the potential to reduce the need for conventional rodent carcinogenicity studies of industrial chemicals, agrochemicals, and pharmaceuticals through a weight-of-evidence approach. These biomarkers fall into 2 major categories: (1) sets of gene transcripts that can identify distinct tumorigenic mechanisms of action; and (2) cancer driver gene mutations indicative of rapidly expanding growth-advantaged clonal cell populations. This call-to-action article describes a collaborative approach launched to develop and qualify biomarker gene expression panels that measure widely accepted molecular pathways linked to tumorigenesis and their activation levels to predict tumorigenic doses of chemicals from short-term exposures. Growing evidence suggests that application of such biomarker panels in short-term exposure rodent studies can identify both tumorigenic hazard and tumorigenic activation levels for chemical-induced carcinogenicity. In the future, this approach will be expanded to include methodologies examining mutations in key cancer driver gene mutation hotspots as biomarkers of both genotoxic and nongenotoxic chemical tumor risk. Analytical, technical, and biological validation studies of these complementary genomic tools are being undertaken by multisector and multidisciplinary collaborative teams within the Health and Environmental Sciences Institute. Success from these efforts will facilitate the transition from current heavy reliance on conventional 2-year rodent carcinogenicity studies to more rapid animal- and resource-sparing approaches for mechanism-based carcinogenicity evaluation supporting internal and regulatory decision-making.

11 June 2012 in Toxicologic Pathology
Verified
Journal Article
Open access
PDF file
APArun R. Pandiri
Arun R. Pandiri
RSRobert C. Sills
Robert C. Sills
VZVincent Ziglioli
Vincent Ziglioli
TTThai-Vu T Ton
Thai-Vu T Ton
HHHue–Hua L. Hong
Hue–Hua L. Hong
MHMark J. Hoenerhoff
Mark J. Hoenerhoff
Lung cancer is the leading cause of cancer-related death in people and is mainly due to environmental factors such as smoking and radon. The National Toxicology Program (NTP) tests various chemicals and mixtures for their carcinogenic hazard potential. In the NTP chronic bioassay using B6C3F1 mice, the incidence of lung tumors in treated and control animals is second only to the liver tumors. In order to study the molecular mechanisms of chemically induced lung tumors, an understanding of the genetic changes that occur in spontaneous lung (SL) tumors from untreated control animals is needed. The authors have evaluated the differential transcriptomic changes within SL tumors compared to normal lungs from untreated age-matched animals. Within SL tumors, several canonical pathways associated with cancer (eukaryotic initiation factor 2 signaling, RhoA signaling, PTEN signaling, and mammalian target of rapamycin signaling), metabolism (Inositol phosphate metabolism, mitochondrial dysfunction, and purine and pyramidine metabolism), and immune responses (FcγR-mediated phagocytosis, clathrin-mediated endocytosis, interleukin 8 signaling, and CXCR4 signaling) were altered. Meta-analysis of murine SL tumors and human non–small cell lung cancer transcriptomic data sets revealed a high concordance. These data provide important information on the differential transcriptomic changes in murine SL tumors that will be critical to our understanding of chemically induced lung tumors and will aid in hazard analysis in the NTP 2-year carcinogenicity bioassays.

21 September 2011 in Toxicologic Pathology
Verified
Journal Article
Open access
PDF file
APArun R. Pandiri
Arun R. Pandiri
RSRobert C. Sills
Robert C. Sills
MHMark J. Hoenerhoff
Mark J. Hoenerhoff
SPShyamal Peddada
Shyamal Peddada
TTThai-Vu T. Ton
Thai-Vu T. Ton
MBMary D. Boudreau
Mary D. Boudreau
Aloe vera is one of the most commonly used botanicals for various prophylactic and therapeutic purposes. Recently, NTP/NCTR has demonstrated a dose-dependent increase in large intestinal tumors in F344 rats chronically exposed to Aloe barbadensis Miller (Aloe vera) non-decolorized whole leaf extract (AVNWLE) in drinking water. The morphological and molecular pathways of AVNWLE-induced large intestinal tumors in the F344 rats were compared to human colorectal cancer (hCRC) literature. Defined histological criteria were used to compare AVNWLE-induced large intestinal tumors with hCRC. The commonly mutated genes (Kras, Ctnnb1, and Tp53) and altered signaling pathways (MAPK, WNT, and TGF-β) important in hCRC were evaluated within AVNWLE-induced large intestinal tumors. Histological evaluation of the large intestinal tumors indicated eight of twelve adenomas (Ads) and four of twelve carcinomas (Cas). Mutation analysis of eight Ads and four Cas identified point mutations in exons 1 and 2 of the Kras gene (two of eight Ads, two of four Cas), and in exon 2 of the Ctnnb1 gene (three of eight Ads, one of four Cas). No Tp53 (exons 5–8) mutations were found in Ads or Cas. Molecular pathways important in hCRC such as MAPK, WNT, and TGF-β signaling were also altered in AVNWLE-induced Ads and Cas. In conclusion, the AVNWLE-induced large intestinal tumors in F344 rats share several similarities with hCRC at the morphological and molecular levels.

1 September 2021 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
TTThai-Vu T. Ton
Thai-Vu T. Ton
RKRamesh C. Kovi
Ramesh C. Kovi
TPTeja N. Peddada
Teja N. Peddada
RCRaveena M. Chhabria
Raveena M. Chhabria
KSKeith R. Shockley
Keith R. Shockley
APArun R. Pandiri
Arun R. Pandiri